home / stock / rvmd / rvmd news


RVMD News and Press, Revolution Medicines Inc. From 11/06/23

Stock Information

Company Name: Revolution Medicines Inc.
Stock Symbol: RVMD
Market: NASDAQ
Website: revmed.com

Menu

RVMD RVMD Quote RVMD Short RVMD News RVMD Articles RVMD Message Board
Get RVMD Alerts

News, Short Squeeze, Breakout and More Instantly...

RVMD - Revolution Medicines Reports Third Quarter 2023 Financial Results and Update on Corporate Progress

Promising clinical data for RMC-6236, a RAS MULTI (ON) Inhibitor, and RMC-6291, a RAS G12C (ON) Inhibitor, presented at AACR-NCI-EORTC (“Triple”) and ESMO Meetings Acquisition of EQRx, Inc. expected to close later this month Revolution Medic...

RVMD - Expected US Company Earnings on Monday, November 6th, 2023

CGG ADR (CGGYY) is expected to report for quarter end 2023-09-30 ATI Physical Therapy Inc. Class A (ATIP) is expected to report $-4.08 for Q3 2023 Riot Platforms Inc. (RIOT) is expected to report $-0.29 for Q3 2023 Bain Capital Specialty Finance Inc. (BCSF) is expected to report $0.57...

RVMD - Expected earnings - Revolution Medicines Inc - Ordinary Shares

Revolution Medicines Inc - Ordinary Shares (RVMD) is expected to report $-1.01 for Q3 2023

RVMD - Catalyst Watch: Disney earnings, Moderna AI event, Powell IMF speech and Las Vegas strike threat

2023-11-03 15:00:40 ET More on the markets SPY: From Bullish To Bearish - Why The Bears Could Be Right This Time (Rating Downgrade) My View Of The S&P 500 November 2023 Edition (Technical Analysis) Famous Chart Pattern Returns To Life Six bullish stocks t...

RVMD - Leading Independent Proxy Advisory Firms ISS and Glass Lewis Recommend Revolution Medicines Stockholders Vote "FOR" Proposed Acquisition of EQRx, Inc.

REDWOOD CITY, Calif., Nov. 01, 2023 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a clinical-stage oncology company developing targeted therapies for RAS-addicted cancers, today announced that leading independent proxy advisory firms, Institutional Shareholder Services Inc. ("ISS...

RVMD - Revolution Medicines to Report Financial Results for Third Quarter 2023 After Market Close on November 6, 2023

REDWOOD CITY, Calif., Oct. 31, 2023 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a clinical-stage oncology company developing novel targeted therapies for RAS-addicted cancers, today announced that it will report financial results for the third quarter 2023 on Monday, November 6...

RVMD - CVM, AUMN and SLNH among mid-day movers

2023-10-23 13:18:40 ET Gainers: LumiraDx Limited ( LMDX ) +186% . Akumin ( AKU ) +178% . Textainer Group Holdings Limited ( TGH ) +44% . Cel-Sci Corp. ( CVM ) +41% . ImmunoPrecise Antibodies Ltd ( IPA ) +27% . Soluna Holdings...

RVMD - Why Revolution Medicines Stock Is Crashing Today

2023-10-23 12:04:10 ET Shares of Revolution Medicines (NASDAQ: RVMD) were crashing 42.5% lower as of 11:13 a.m. ET on Monday. The steep decline came after the oncology company presented results on Sunday for RMC-6236 from a phase 1 study targeting the treatment of non-small cell lun...

RVMD - Revolution Medicines falls after early-stage data for cancer therapy

2023-10-23 09:03:43 ET More on Revolution Medicines Revolution Medicines: A Big Pipeline In Need Of Big Data Revolution Medicines' Strategic Edge In RAS-Driven Oncology Revolution Medicines, Inc. (RVMD) Q2 2023 Earnings Call Transcript Why did Revolution Medi...

RVMD - OKTA, AMWL and ORMP among pre-market losers

2023-10-23 08:31:36 ET Losers: Revolution Medicines ( RVMD ) -31% . Troika Media Group ( TRKA ) -21% . Li-Cycle Holdings Corp ( LICY ) -21% announces review of the rochester hub project . Mmtec ( MTC ) -18% . Palatin Technologies ( ...

Previous 10 Next 10